General Information


DRAVP ID  DRAVPe00074

Peptide Name   4324(derived from the RNase H domain of HIV-1 RT (20-mes))

Sequence  EQVDKLVSAGIRKVLFLDGI

Sequence Length  20

UniProt ID  No entry found

Source  Synthetic construct(derived from HIV-1 Reverse Transcriptase)



Activity Information


Target Organism  HIV

Assay  Dot-blot assay

Activity 

  • [Ref.15790559]HIV-1:the level of peptide binding to HIV integrase is high.

Hemolytic Activity  No hemolysis information or data found in the reference(s) presented in this entry

Cytotoxicity 

  • No cytotoxicity information or data found in the reference(s) presented in this entry

Binding Target  Integrase

Mechanism  Two viral encoded enzymes(reverse transcriptase and integrase) play central roles in the early stages of the replication of retroviruses and retrotransposons.The peptide derived from the RNase H domain of HIV-1 RT inhibits integrase-associated activities (3′-end processing and strand transfer) and inhibit virus replication.



Structure Information


PDB ID  None

Predicted Structure Download  DRAVPe00074

Linear/Cyclic  Linear

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Stereochemistry  L



Physicochemical Information


Formula  C100H170N26O29

Absent amino acids  CHMNPTWY

Common amino acids  LV

Mass  2200.61

Pl  6.22

Basic residues  3

Acidic residues  3

Hydrophobic residues  10

Net charge  0

Boman Index  -1582

Hydrophobicity  48.5

Aliphatic Index  146

Half Life 

  •     Mammalian:1 hour
  •     Yeast:30 min
  •     E.coli:>10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  3



Literature Information


Literature 1

Title   Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.

Pubmed ID   15790559

Reference   J Biol Chem. 2005 Jun 10;280(23):21987-96.

Author   Oz Gleenberg I, Avidan O, Goldgur Y, Herschhorn A, Hizi A.

DOI   10.1074/jbc.M414679200